证券代码：603665 证券简称：康隆达 公告编号：2025-060 浙江康隆达特种防护科技股份有限公司 关于股东部分股份解除质押及质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司股东张间芳先生持有上市公司股份 5,190,000 股，占公司总股本的 3.22%；本次解除质押后，张间芳先生累计质押股份数为 0 股。绍兴上虞东大针 织有限公司（以下简称"东大针织"）持有上市公司股份 25,410,611 股，占公 司总股本的 15.77%；本次股份质押后，东大针织累计质押股份数为 25,104,730 股，占其持有公司股份总数的 98.80%，占公司总股本的 15.58%。 | | 是否 | | 是否为限 | 是 否 | | | | 占其 所持 | 占公 司总 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 为控 | 本次质押 | 售股（如 | 补 | | | | | | 融资 | ...

证券代码：603665 证券简称：康隆达 公告编号：2025-059 浙江康隆达特种防护科技股份有限公司 关于股东权益变动的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次权益变动概述 浙江康隆达特种防护科技股份有限公司（以下简称"公司"或"康隆达"） 股东绍兴上虞东大针织有限公司（以下简称"东大针织"）与公司实际控制人之 一张间芳先生于 2022 年 1 日 6 日签署了《股份转让协议》，东大针织以协议转让 方式将其持有的公司 24,000,000 股股份转让给张间芳先生，并于 2022 年 3 月 17 日完成了标的股份的过户手续。（公告编号：2022-001、2022-010） 根据绍兴市上虞区人民法院（以下简称"上虞法院"）出具的（2024）浙 0604 诉前调确 835 号《民事裁定书》，张间芳先生将该 24,000,000 股返还给东大针织， 并办理过户登记手续。上虞法院裁定确认以上调解协议有效。信息披露义务人履 行法院出具的确认调解协议效力的民事裁定。具体内容详见公司在上海证券交易 所网站披露的 ...

2025 年 7 月 4 日,浙江康隆达特种防护科技股份有限公司（以下简称"公司"） 分别收到张间芳先生和东大针织的通知，获悉张间芳先生将持有的本公司股份进 行了解除质押和东大针织将持有的本公司股份进行了质押。具体情况如下： | 股东名称 | 张间芳 | | --- | --- | | 本次解质股份（股） | 2,500,000 | | 占其所持股份比例(%) | 32.51 | | 占公司总股本比例(%) | 1.55 | | 解质时间 | 2025 年 7 月 3 日 | 证券代码：603665 证券简称：康隆达 公告编号：2025-058 浙江康隆达特种防护科技股份有限公司 关于股东部分股份解除质押及质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司股东张间芳先生持有上市公司股份 7,690,000 股，占公司总股本的 4.77%；本次解除质押后，张间芳先生累计质押股份数为 5,190,000 股，占其持 有公司股份总数的 67.49%，占公司总股本的 3.22%。绍兴上虞东大针织有限公司 ...

Core Viewpoint - 康隆达's acquisition of Jiangxi Tiancheng Lithium Industry Co., Ltd. has led to significant financial losses due to unmet performance commitments, resulting in regulatory penalties for the counterparties involved [1][6]. Group 1: Acquisition and Performance Commitments - 康隆达 acquired a 17.67% stake in Tiancheng Lithium for 212 million yuan in September 2022, making it a subsidiary [1][4]. - The performance commitments for Tiancheng Lithium were set at net profits of no less than 180 million yuan, 200 million yuan, and 210 million yuan for the years 2022, 2023, and 2024, respectively [4]. - Tiancheng Lithium achieved a total net profit of 267 million yuan from 2022 to 2024, resulting in a performance completion rate of 45.2% [4]. Group 2: Financial Impact - 康隆达 reported a cumulative loss of 706 million yuan in net profit for 2023 and 2024, primarily due to the underperformance of Tiancheng Lithium [2][9]. - The company recognized goodwill impairment losses totaling 396 million yuan related to the acquisition of Tiancheng Lithium [2][9]. - In 2022, 康隆达's revenue was 1.374 billion yuan, a 30.55% increase year-on-year, but the company faced losses in subsequent years due to the underperformance of its lithium segment [8][9]. Group 3: Regulatory Actions - The Zhejiang Securities Regulatory Bureau imposed corrective measures on the performance commitment parties for failing to fulfill their obligations, which will be recorded in the securities market integrity archives [1][6]. - 康隆达 has indicated plans to pursue legal avenues to recover the 116 million yuan in cash compensation owed by the performance commitment parties [7]. Group 4: Business Operations - 康隆达's main business remains in protective gloves, with significant revenue contributions from this segment despite challenges in the lithium business [9]. - The company is also developing a production base in Vietnam for its protective glove products, which is expected to enhance revenue in 2025 [10].

Core Viewpoint - 康隆达 faces significant challenges due to the failure of its subsidiary, 天成锂业, to meet performance commitments, leading to regulatory actions and financial losses [1][3][5] Group 1: Company Performance and Financials - 康隆达's stock price has dropped from a peak of 56.48 yuan per share in June 2022 to 14.41 yuan per share by the end of 2024, representing a cumulative decline of 74.49% [3] - The company reported a total net loss of 706 million yuan over 2023 and 2024, with 天成锂业 achieving only 267 million yuan in net profit against a commitment of 590 million yuan over three years, resulting in a performance completion rate of 45.20% [3][4] - 康隆达 received a total of 1.16 billion yuan in cash compensation from 天成管理 and 亿源锂 due to the unmet performance commitments [3] Group 2: Regulatory Actions - 浙江证监局 issued a decision requiring 天成管理, 亿源锂, and others to rectify their failure to fulfill performance commitments, marking this as a violation of their obligations [1][5] - The Shanghai Stock Exchange also imposed disciplinary actions against the involved parties, including public reprimands, due to the violations [1][5] Group 3: Market Context and Future Outlook - 康隆达's involvement in the lithium sector initially brought substantial returns, with revenues from "lithium salts" and "lithium salt processing" reaching 721.35 million yuan and 1.80 billion yuan respectively in 2022, with gross margins significantly higher than its core business of functional gloves [2] - Despite recent stock price recovery, the company announced the termination of its "annual production of 2400 tons of multifunctional, high-performance polyethylene fiber project," reallocating the remaining funds to supplement working capital [6]

Group 1 - CITIC Construction Investment has received approval from the China Securities Regulatory Commission to issue perpetual subordinated bonds with a total face value of no more than 20 billion yuan [1] - Bluefocus Technology has received a loan commitment of up to 900 million yuan from CITIC Bank for stock repurchase [1] - Huaren Pharmaceutical's subsidiary has received approval for the listing of Bumetanide raw materials, which are used to treat severe heart failure and hypertension emergencies [3] Group 2 - Betta Pharmaceuticals has received approval for the listing of Enasidenib capsules in Macau, aimed at treating ALK-positive locally advanced or metastatic non-small cell lung cancer [4] - Juewei Food plans to use 110 million yuan of idle fundraising for cash management, with an expected annual yield of 1.00%-1.89% [6] - China Huadian has successfully completed the issuance of 1 billion yuan medium-term notes with a coupon rate of 1.95% [9] Group 3 - Fosun Pharma's subsidiary has received a GMP certificate from the Belgian Federal Agency for Medicines and Health Products for the production facilities of two monoclonal antibodies [11] - China Nuclear Engineering has signed a civil engineering contract for the Taishan Nuclear Power Units 3 and 4 [13] - Kanglongda has faced administrative regulatory measures from the Zhejiang Securities Regulatory Bureau due to the failure of performance commitment parties to fulfill compensation obligations [15] Group 4 - Gaoling Information has received three invention patent certificates in the second quarter, covering various technological fields [16] - Weimais plans to use 190 million yuan of excess fundraising to increase capital in its subsidiary for building a new energy vehicle powertrain production base [17] - Huazhong Technology has received a project designation notice from a leading eVTOL manufacturer for the development and supply of an intelligent cockpit multimedia display system [19] Group 5 - Madi Technology expects a net profit of 25 million to 27 million yuan for the first half of 2025, marking a turnaround from a loss in the previous year [19] - Dazhong Mining's subsidiary has obtained a mining license for the Zhouyoufang Iron Mine, increasing production capacity to 6.5 million tons per year [20] - Zhongguancun's subsidiary has had its application for the listing of Arolol hydrochloride tablets accepted by the National Medical Products Administration [21] Group 6 - Tianhong Co. has signed a property management contract worth 15 million yuan with a local company [22] - Dong'an Power has secured nine new market designation agreements in the second quarter, with a projected total sales volume of 1.5 million units [24] - Zhujiang Co. has appointed Zhao Kun as the new deputy general manager [25] Group 7 - Jinyi Industrial has won a bid for a project worth 335 million yuan from the China Railway Shanghai Bureau Group [26] - Kangchen Pharmaceutical has received a clinical trial notification for its innovative drug KC1086, aimed at treating advanced solid tumors [27] - Changhua Group has received a project designation notice from a new energy vehicle company, with an expected total sales amount of 970 million yuan [29] Group 8 - Lingxiao Pump Industry plans to use 60 million yuan of idle funds to purchase financial products [31] - Mould Technology has received a project designation for exterior parts from a well-known North American electric vehicle company, with an expected total sales of 1.236 billion yuan [34] - Fulongma has pre-bid for five sanitation service projects in June, with a total contract amount of 181 million yuan [35] Group 9 - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange [36] - *ST Yuancheng is under investigation by the CSRC for suspected false financial disclosures [37] - Beilu Pharmaceutical's subsidiary has received approval for the listing of Iopamidol raw materials [38] Group 10 - Zhejiang Liming's shareholder plans to reduce their stake by up to 2.93% [39] - Zhejiang Liming's actual controller has committed not to reduce their holdings within a year [40] - SAIC Motor reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [41] Group 11 - Xinhongcheng expects a net profit increase of 50%-70% for the first half of 2025 [42] - Xianhe Co. plans to invest 11 billion yuan in a bamboo pulp paper integrated project [42] - Great Wall Motors reported a total vehicle sales of 569,800 units in the first half of 2025, a year-on-year increase of 1.81% [43] Group 12 - Dongfeng Co. received a government subsidy of 10 million yuan [44] - Zhongke Environmental Protection has acquired two water environmental companies in Guangxi for a total of 353 million yuan [45] - Anji Food's H-share public offering is priced at 60 Hong Kong dollars per share [46]

浙江康隆达特种防护科技股份有限公司（以下简称"公司"或"康隆达"） 股东绍兴上虞东大针织有限公司（以下简称"东大针织"）与公司实际控制人之 一张间芳先生于 2022 年 1 日 6 日签署了《股份转让协议》，东大针织以协议转让 方式将其持有的公司 24,000,000 股股份转让给张间芳先生，并于 2022 年 3 月 17 日完成了标的股份的过户手续。（公告编号：2022-001、2022-010） 证券代码：603665 证券简称：康隆达 公告编号：2025-056 浙江康隆达特种防护科技股份有限公司 关于股东权益变动的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次权益变动概述 三、其他说明 本次权益变动系东大针织与其实际控制人张间芳先生之间的股份回转，变动 双方存在实际控制关系，不触及要约收购。本次权益变动完成后将导致公司控股 股东由张间芳先生变更为东大针织，但不会导致公司实际控制人发生变化。 公司将持续关注相关事项的进展，并按照有关法律法规的要求及时履行信息 披露义务。请广大投资者理性投资，注意投资 ...

一、《决定书》主要内容 "宜春丙戊天成管理咨询中心（有限合伙）、宜春亿源锂咨询中心（有限合 伙）、江西天成锂业有限公司、董爱华、李锦萍： 经查，2022 年 9 月，浙江康隆达特种防护科技股份有限公司(以下简称康隆 达或公司)与你们签订《股权转让协议》, 约定康隆达以人民币 21,200 万元分别 向宜春丙戊天成管理咨询中心(有限合伙)(以下简称天成管理)、宜春亿源锂咨 询中心(有限合伙)(以下简称亿源锂)收购其所持有的江西天成锂业有限公司(以 下简称天成锂业)11.31%、6.36%的股权。天成管理、亿源锂承诺天成锂业在 2022 年、2023 年和 2024 年内实现的净利润分别不低于 18,000 万元、20,000 万元和 21,000 万元。若天成锂业在 2022-2024 年累计 3 个会计年度实际实现的净利润 未能达到 3 年承诺净利润目标，天成管理、亿源锂应在接到公司通知后的 30 日 内以现金方式对公司予以补偿。天成锂业、董爱华及李锦萍对天成管理及亿源锂 的前述业绩补偿义务承担不可撤销的连带担保责任。 根据中汇会计师事务所(特殊普通合伙)出具的《关于江西天成锂业有限公司 业绩承诺完成情况的鉴 ...

Fundraising Overview - The company, Zhejiang Kanglongda Special Protective Technology Co., Ltd., issued 2,000,000 convertible bonds on April 23, 2020, with a face value of RMB 100 each, raising a total of RMB 200 million [1] - The funds raised were managed under a dedicated account system, in compliance with relevant laws and regulations [1][2] Fund Management and Supervision - The company established a fundraising management system and signed a tripartite supervision agreement with its sponsor, CITIC Securities, and Bank of China, ensuring proper management and usage of the funds [1] - The dedicated accounts were opened at Bank of China and China Minsheng Bank, with specific account numbers provided [3][2] Account Cancellation - On June 11, 2025, the company’s board and supervisory board approved the termination of an investment project related to the production of high-performance polyethylene fibers and decided to permanently supplement the remaining funds into working capital [3][4] - As of July 1, 2025, the company transferred a total of RMB 89,725,510.27, including interest income, to its ordinary account and completed the cancellation of the dedicated fundraising accounts [4][5]

一、募集资金基本情况 经中国证券监督管理委员会"证监许可[2019]2287 号"文核准，公司于 2020 年 4 月 23 日向社会公开发行可转换公司债券 2,000,000 张，每张面值为人民币 100 元，按面值发行，发行总额为人民币 20,000.00 万元，扣除本次发行费用 690.47 万元（不含税）后，实际可用募集资金净额为 19,309.53 万元。上述募 集资金到位情况已经中汇会计师事务所（特殊普通合伙）审验，并由其出具了《验 证报告》（中汇会验[2020]2821 号）予以确认。公司对募集资金采取了专户存储 制度。 二、募集资金存放和管理情况 1.为规范募集资金的管理和使用，提高资金使用效率和效益，保护投资者利 益，公司根据《公司法》、《证券法》、《上市公司监管指引第2号——上市公 司募集资金管理和使用的监管要求》、《上海证券交易所股票上市规则》及《上 海证券交易所上市公司自律监管指引第1号——规范运作》等有关法律、法规和 规范性文件的规定，结合公司实际情况，公司制定了《浙江康隆达特种防护科技 股份有限公司募集资金管理制度》(以下简称《募集资金管理制度》)。根据《募 集资金管理制度》，公司 ...